Newsletter | November 22, 2024

11.22.24 -- Tips For Scaling mRNA Therapeutics

FOCUS ON CLINICAL TRIALS

Tips For Scaling mRNA Therapeutics

In this segment, Joseph Barberio of Strand Therapeutics and Christian Moreno of Nutcracker Therapeutics share their insight on what’s needed to achieve success in scaling mRNA therapeutics.

Understanding The Cold Durability Performance Of Fluoropolymer Bags

Although polymer bags are an excellent choice for cold chain use, not all polymer films perform the same way, even if their specifications rate them for use at low temperatures.

FOCUS ON SUPPLY CHAIN

Improving TCR T-Cell Persistence And Efficacy With Adaptimmune

On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Dennis Williams, Senior Vice President of Late Stage Development at Adaptimmune. Williams shares valuable insights into the groundbreaking world of TCR T-cell therapies, with a focus on the TECELRA trial.

How Does The Australian Advantage Maximize Benefits For U.S. Biotechs?

The "Australian Advantage" approach offers U.S. biotech firms numerous benefits, including a cash rebate of almost 50%, faster timelines, no IND requirement, and globally accepted data.

The Critical Role Of The Medical Monitor

Medical Monitors interact with nearly all functional roles on a study team and more experienced monitors often support and mentor less-experienced colleagues.

Expert Insights In Navigating CGT's Complex Supply Chain

Examine insights shared during Cencora's ThinkLive Cell and Gene Therapy Summit 2024 that shed light on the challenges and opportunities in navigating the complexities of the cell and gene supply chain.

Are You Using Real-World Evidence?

This series of case studies illustrates how Real-World Evidence (RWE) can enhance decision-making processes, leading to more efficient development strategies that save both time and costs.

SUPPLY CHAIN SOLUTIONS

The Modern, Flexible, Easy-To-Integrate EDC You've Been Looking For - OpenClinica

Connect With Cell & Gene: